A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects
Status:
Completed
Trial end date:
2020-09-20
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the effect of Rifampin on pharmacokinetics
of healthy Chinese adult subjects after oral administration of SHR2554 tablets. The secondary
objective of the study is to evaluate the safety of single-dose oral administration of
SHR2554 in healthy subjects.